Severe Pulmonary Toxicity in Patients With Advanced-Stage Hodgkin's Disease Treated With a Modified Bleomycin, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone, and Gemcitabine (BEACOPP) Regimen Is Probably Related to the Combination of Gemcitabine and Bleomycin: A Report of the German Hodgkin's Lymphoma Study Group
- 15 June 2004
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (12), 2424-2429
- https://doi.org/10.1200/jco.2004.09.114
Abstract
Purpose To investigate a new effective, nonleukemogenic polychemotherapy regimen, BAGCOPP (bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, gemcitabine) in a phase I...Keywords
This publication has 31 references indexed in Scilit:
- Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin diseaseCancer, 2003
- Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 2003
- Gemcitabine-Associated Pneumocystis carinii PneumoniaClinical Drug Investigation, 2000
- Drug-Induced Respiratory DisordersDrug Safety, 2000
- BEACOPP: A new regimen for advanced Hodgkin’s diseaseAnnals of Oncology, 1998
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- Oral Dexamethasone for the Amelioration of the Gemcitabine-Induced Side Effects Asthenia, Edema, and Flu-Like SymptomsOncology Research and Treatment, 1998
- Gemcitabine—a safety reviewAnti-Cancer Drugs, 1998
- Dose-escalation study for the treatment of Hodgkin's diseaseAnnals of Hematology, 1993
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975